BDUUF vs ABBV: Which Stock is Better?
Side-by-side comparison of Bangkok Dusit Medical Services Public Company Limited and Abbvie Inc in 2026
BDUUF
Bangkok Dusit Medical Services Public Company Limited
$0.65
ABBV
Abbvie Inc
$203.71
Key Metrics Comparison
| Metric | BDUUF | ABBV | Winner |
|---|---|---|---|
| Market Cap | $10.33B | $368.57B | ABBV |
| P/E Ratio | 21.67 | 87.55 | BDUUF |
| EPS (TTM) | $0.03 | $2.38 | ABBV |
| Revenue Growth | 0.0% | 0.1% | ABBV |
| Gross Margin | 37.1% | 71.6% | ABBV |
Analyze BDUUF
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BDUUF or ABBV a better investment?
Comparing BDUUF and ABBV: Bangkok Dusit Medical Services Public Company Limited has a market cap of $10.33B while Abbvie Inc has $368.57B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BDUUF and ABBV?
BDUUF (Bangkok Dusit Medical Services Public Company Limited) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BDUUF or ABBV?
Based on P/E ratios, BDUUF trades at a lower multiple (21.7x vs 87.6x).
Which is growing faster: BDUUF or ABBV?
ABBV has higher revenue growth at 0.1% vs 0.0% for BDUUF.
Which company is more profitable: BDUUF or ABBV?
Abbvie Inc (ABBV) has higher gross margins at 71.6% compared to 37.1% for BDUUF.
Which is the larger company: BDUUF or ABBV?
Abbvie Inc (ABBV) is larger with a market cap of $368.57B compared to $10.33B for BDUUF.
Should I buy BDUUF or ABBV in 2026?
Both BDUUF and ABBV have investment merit. BDUUF trades at $0.65 while ABBV trades at $203.71. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between BDUUF and ABBV stock?
Key differences: Market Cap ($10.33B vs $368.57B), P/E Ratio (21.7x vs 87.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (37.1% vs 71.6%).